A searchable database of
medically documented cases

About the Project

Spontaneous Remission In A Child With An Nphs1-based Congenital Nephrotic Syndrome

Espinosa, L. G. 2022Other/Unknown

Espinosa, L. G., Santoveña, A. Z., Blanco, J. N., Alvariño, M. G., Feito, J. B., & Hijosa, M. M. (2022). Spontaneous remission in a child with an NPHS1-based congenital nephrotic syndrome. Clinical kidney journal, 15(10), 1969–1970. https://doi.org/10.1093/ckj/sfac086

View Original Source →

Abstract

Congenital nephrotic syndrome (CNS) refers to disease present-ing within the first 3 months of life. Mutations in five different genes ( NPHS1 , NPHS2 , PLCE1 , WT1 and LAMB2 ) are responsible for > 80% of cases [1]. The disease is classically considered as irreversible, progressing in early infancy to end-stage renal disease (ESRD). Although some NPHS1 mutations have been associated with a more favorable evolution [2], only anecdotal cases of spontaneous remission have been reported. We present an 11-day-old male term neonate who was ad-mitted in hospital with a generalized seizure. Pregnancy ultra-sounds were normal; no polyhydramnios or placental edema was reported. Nuclear magnetic resonance imaging diagnosed a cerebral venoussinusthrombosis.Physicalexaminationshowed palpebral and lower limb edema. Laboratory tests showed albumin 0.5 g/dL, total proteins 3.2 g/dL,

Case Details

Disease Location

Kidney, blood

Personal Characteristics

11-day-old male

Clinical Characteristics

Admitted with a generalized seizure. Nuclear magnetic resonance imaging diagnosed a cerebral venous sinus thrombosis. Laboratory tests showed proteinuria and hypoalbuminuria. Genetic study showed a compound heterozygous for two different sequence variants in exons 9 and 27 of the nphs1 gene. Anticoagulant, antiproteinuric and diuretic treatment was started. Anticoagulant treatment was maintained for 3 years and it was replaced by antiplatelet therapy for one more year.

Remission Characteristics

After 6 months, a progressive increase in serum albumin with a parallel decrease in proteinuria was observed until normalization at 18 months

Treatment & Mechanisms

Clinical Treatment

Anticoagulant, antiproteinuric, diuretic treatment, antiplatelet therapy